Looking forward to an exciting year ahead - well and truly settled into our new BioHub HQ.
🌟Opportunity North East Limited asked the innovative tenants of ONE BioHub what their hopes are for 2025. From groundbreaking research to industry-defining collaborations, these companies are shaping a vision of growth and opportunity that could strengthen the region’s position as a hub for innovation. Their ambitions reflect a shared commitment to advancing science and contributing to the economic vitality of our community. Here’s a glimpse into their ambitions: 🎯 NovaBiotics Ltd: CEO Deborah O’Neil OBE FRSE shares plans to expand commercial activities globally, including scaling sales of their Tinexyl® range and advancing their pharma pipeline. With their relocation to ONE BioHub, NovaBiotics is perfectly positioned to thrive as a commercial-stage biotech business. 🧠 Scottish Brain Sciences: Founder Prof. Craig Ritchie highlights a transformative year ahead, with significant research growth, expanded regional engagement, and plans to broaden their business model beyond Scotland—bringing brain health research opportunities to more people. 🧬 Genomes.io: Founder Aldo de Pape reflects on remarkable 2024 growth and looks forward to 2025 with plans for new health reports, user growth, and impactful collaborations, including an AI-driven algorithm to improve drug response predictions. These pioneering businesses continue to expand and thrive, driving economic growth and solidying the region's reputation as a leader in the life sciences industry—ONE BioHub tenants are laying the foundation for a brighter future. 🚀 What are your hopes for the year ahead? 📰 Read the full article: https://lnkd.in/e6PhcTtX #LifeSciences #Innovation #ONEBioHub